Clinical effect of cefuzonam against infectious diseases in obstetrics and gynecology
Chimura, T.; Watanabe, T.; Inoue, K.; Yoshimura, Y.
Japanese Journal of Antibiotics 40(5): 995-1000
1987
ISSN/ISBN: 0368-2781 PMID: 3669292 Document Number: 301754
Clinical studies of cefuzonam (CZON, L-105) were performed in patients of obstetrics and gynecology, and the results obtained are summarized below. 1. CZON was intravenously administered at a daily dose of 1 .times. 2 g to 11 cases including 3 cases with intrauterine infection (pyometra), 2 cases of intrapelvic infection (1 case of pelvic dead space infection and 1 case of pelvic peritonitis), 1 case of adnexitis, and other (2 cases of vaginal cuff infection, and 1 case each of vaginal abscess, BALTHOLIN's abscess, and vulvar abscess). Clinical efficacy was excellent in 1 case and good in 10 cases. 2. CZON showed a good antibacterial effect in single and mixed infections. 3. Neither side effects nor abnormal values in clinical laboratory findings attributable to the drug were observed.